Okada M et al. |
Successful treatment of chronic graft-versus-host disease with sulfasalazine in allogeneic bone marrow transplantation. |
1999 |
Acta Haematol. |
pmid:10529517
|
Morita H et al. |
Immunosuppressive effect of leukotriene B(4) receptor antagonist in vitro. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10529362
|
Cannon RD et al. |
Clinical efficacy of the Abbott Tacrolimus II assay for the IMx. |
1999 Oct-Dec |
Ann. Clin. Lab. Sci. |
pmid:10528829
|
Grimbert P et al. |
Tacrolimus (FK506)-induced severe and late encephalopathy in a renal transplant recipient. |
1999 |
Nephrol. Dial. Transplant. |
pmid:10528682
|
Shadidy M et al. |
Biochemical analysis of mouse FKBP60, a novel member of the FKPB family. |
1999 |
Biochim. Biophys. Acta |
pmid:10524204
|
Lee SF et al. |
Cytokine receptor common beta chain as a potential activator of cytokine withdrawal-induced apoptosis. |
1999 |
Mol. Cell. Biol. |
pmid:10523628
|
Mao Z and Wiedmann M |
Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons. |
1999 |
J. Biol. Chem. |
pmid:10521511
|
Hübner GI et al. |
Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients. |
1999 |
Ther Drug Monit |
pmid:10519451
|
Yoshimoto T and Siesjö BK |
Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. |
1999 |
Brain Res. |
pmid:10519051
|
Pacocha SE et al. |
Regulation of antigen-induced human T-lymphocyte responses by calcineurin antagonists. |
1999 |
J. Allergy Clin. Immunol. |
pmid:10518828
|
Bekersky I et al. |
Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study design. |
1999 |
J Clin Pharmacol |
pmid:10516937
|
Przepiorka D et al. |
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation. |
1999 |
Bone Marrow Transplant. |
pmid:10516680
|
Moore JM |
NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery. |
1999 |
Biopolymers |
pmid:10516573
|
Cardenas ME et al. |
Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. |
1999 |
Clin. Microbiol. Rev. |
pmid:10515904
|
Cunningham EB |
An inositolphosphate-binding immunophilin, IPBP12. |
1999 |
Blood |
pmid:10515881
|
Fan L et al. |
Improved artificial death switches based on caspases and FADD. |
1999 |
Hum. Gene Ther. |
pmid:10515447
|
Charney DA et al. |
Plasma cell-rich acute renal allograft rejection. |
1999 |
Transplantation |
pmid:10515379
|
Rostaing L et al. |
Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. |
1999 |
Clin Transplant |
pmid:10515221
|
Robinson BV et al. |
Optimal dosing of intravenous tacrolimus following pediatric heart transplantation. |
1999 |
J. Heart Lung Transplant. |
pmid:10512526
|
Dusting GJ et al. |
Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms. |
1999 |
Br. J. Pharmacol. |
pmid:10510443
|